Opioids as modulators of cell death and survival - Unraveling mechanisms and revealing new indications

Pharmacological Reviews

Volumn 56, Issue 3, 2004, Pages 351-369

  Tegeder, Irmgard ^a,b   Geisslinger, Gerd ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; CALMODULIN; CHEMOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIATE; OPIATE RECEPTOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ANALGESIA; ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE RELEASE; DRUG ABUSE; DRUG DEPENDENCE; DRUG MECHANISM; ENZYME ACTIVATION; GROWTH REGULATION; HEALING; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; CELL DEATH; CELL LINE; CELL SURVIVAL; HUMANS; MODELS, BIOLOGICAL; NARCOTICS;

EID: 4143066901     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.56.3.2     Document Type: Review

References (261)

1. Adarichev VA, Vaiskunaite R, Niu J, Balyasnikova IV, and Voyno-Yasenetskaya TA (2003) G alpha 13-mediated transformation and apoptosis are permissively dependent on basal ERK activity. Am J Physiol Cell Physiol 285:C922-C934.
2. Adayev T, Ray I, Sondhi R, Sobocki T, and Banerjee P (2003) The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha. Biochim Biophys Acta 7:85-96.
3. Aley KO, Messing RO, Mochly-Rosen D, and Levine JD (2000) Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 20:4680-4685.
4. Alicea C, Belkowski S, Eisenstein TK, Adler MW, and Rogers TJ (1996) Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H. J Neuroimmunol 64:83-90.
5. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, and Williams JT (2002) mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22:5769-5776.
6. Azuma Y and Ohura K (2002) Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions and potentiate NF-kappaB DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol 56:260-269.
7. Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P, Ravetti JL, Zona G, Spaziante R, Florio T, et al. (2002) Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci 973:60-69.
8. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, and Schettini G (2003) Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63:1969-1974.
9. Beagles K, Wellstein A, and Bayer B (2004) Systemic morphine administration suppresses genes involved in antigen presentation. Mol Pharmacol 65:437-442.
10. Belcheva MM, Haas PD, Tan Y, Heaton VM, and Coscia CJ (2002) The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J Pharmacol Exp Ther 303:909-918.
11. Belcheva MM, Szucs M, Wang D, Sadee W, and Coscia CJ (2001) mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:33847-33853.
12. Belcheva MM, Vogel Z, Ignatova E, Avidor-Reiss T, Zippel R, Levy R, Young EC, Barg J, and Coscia CJ (1998) Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J Neurochem 70:635-645.
13. Belkowski SM, Alicea C, Eisenstein TK, Adler MW, and Rogers TJ (1995) Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50,488H. J Pharmacol Exp Ther 273:1491-1496.
14. Berhow MT, Hiroi N, and Nestler EJ (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707-4715.
15. Bertelsen LS, Barrett KE, and Keely SJ (2004) Gs protein-coupled receptor agonists induce transactivation of the epidermal growth factor receptor in T84 cells: implications for epithelial secretory responses. J Biol Chem 279:6271-6279.
16. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, and Luger TA (1996) Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 156:2517-2521.
17. Bigliardi PL, Sumanovski LT, Buchner S, Rufli T, and Bigliardi-Qi M (2003) Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression. J Investig Dermatol 120:145-152.
18. Bigliardi-Qi M, Bigliardi PL, Eberle AN, Buchner S, and Rufli T (2000) beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J Investig Dermatol 114:527-532.
19. Bilfinger TV, Fimiani C, and Stefano GB (1998) Morphine's immunoregulatory actions are not shared by fentanyl. Int J Cardiol 64 (Suppl 1):S61-S66.
20. Bohn LM, Lefkowitz EJ, and Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:10494-10500.
21. Bohn LM, Lefkowitz EJ, Gainetdinov RR, Peppel K, Caron MG, and Lin FT (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science (Wash DC) 286:2495-2498.
22. Boronat MA, Garcia-Fuster MJ, and Garcia-Sevilla JA (2001) Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 134:1263-1270.
23. Boyadjieva N, Dokur M, Advis JP, Meadows GG, and Sarkar DK (2001) Chronic ethanol inhibits NK cell cytolytic activity: role of opioid peptide beta-endorphin. J Immunol 167:5645-5652.
24. Brack A, Rittner HL, Machelska H, Beschmann K, Sitte N, Schafer M, and Stein C (2004) Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 100:149-157.
25. Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, Spicher K, Schultz G, and Nurnberg B (2003) Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J Cell Biol 160:89-99.
26. Buchanan FG, Wang D, Bargiacchi F, and DuBois RN (2003) Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278:35451-35457.
27. Burger M, Glodek A, Hartmann T, Schmitt-Graff A, Silberstein LE, Fujii N, Kipps TJ, and Burger JA (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation and adhesion to stromal cells. Oncogene 22:8093-8101.
28. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schafer M, Loeffler JP, and Stein C (1997) Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Investig 100:142-148.
29. Cabot PJ, Carter L, Schafer M, and Stein C (2001) Methionine-enkephalin- and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 93:207-212.
30. Cao Z, Liu L, and Van Winkle DM (2003) Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol 285:H1032-H1039.
31. Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, and Guzman M (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Investig 111:43-50.
32. Chao CC, Gekker G, Hu S, Sheng WS, Shark KB, Bu DF, Archer S, Bidlack JM, and Peterson PK (1996) Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc Natl Acad Sci USA 93:8051-8056.
33. Chao CC, Gekker G, Sheng WS, Hu S, Portoghese PS, and Peterson PK (1995) Endogenous opioid peptides suppress cytokine-mediated up-regulation of HIV-1 expression in the chronically infected promonocyte clone U1. Adv Exp Med Biol 373:65-72.
34. Chao CC, Hu S, Gekker G, Lokensgard JR, Heyes MP, and Peterson PK (2000) U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression. Neuropharmacology 39:150-160.
35. Chao CC, Hu S, Molitor TW, Zhou Y, Murtaugh MP, Tsang M, and Peterson PK (1992) Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther 262:19-24.
36. Chavkin C, James IF, and Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (Wash DC) 215:413-415.
37. Chen C, Li J, Bot G, Szabo I, Rogers TJ, and Liu-Chen LY (2004) Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483:175-186.
38. Cheng K, Zimniak P, and Raufman JP (2003) Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res 63:6744-6750.
39. Cho CH, Wu KK, Wu S, Wong TM, So WH, Liu ES, Chu KM, Shin VY, Ye YN, and Wong BC (2003) Morphine as a drug for stress ulcer prevention and healing in the stomach. Eur J Pharmacol 460:177-182.
40. Chu P, Murray S, Lissin D, and von Zastrow M (1997) Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272:27124-27130.
41. Chuang LF, Killam KF Jr, and Chuang RY (1997) Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate. J Biol Chem 272:26815-26817.
42. Chuang TT, Iacovelli L, Sallese M, and De Blasi A (1996) G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci 17:416-421.
43. Crain SM and Shen KF (1995) Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci USA 92:10540-10544.
44. Czupalla C, Culo M, Muller EC, Brock C, Reusch HP, Spicher K, Krause E, and Nurnberg B (2003) Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 278: 11536-11545.
45. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, and Bunnett NW (2000) beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
46. Deng W, Balazs L, Wang DA, Van Middlesworth L, Tigyi G, and Johnson LR (2002) Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis. Gastroenterology 123:206-216.
47. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, and Di Marzo V (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 95:8375-8380.
48. Dermott JM, Reddy MR, Onesime D, Reddy EP, and Dhanasekaran N (1999) Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene 18:7185-7189.
49. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (Lond) 399:601-605.
50. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, and Greenberg ME (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (Wash DC) 275:661-665.
51. Edamatsu H, Kaziro Y, and Itoh H (1998) Expression of an oncogenic mutant G alpha i2 activates Ras in Rat-1 fibroblast cells. FEBS Lett 440:231-234.
52. Elmer GI, Pieper JO, Negus SS, and Woods JH (1998) Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75:129-140.
53. Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V, and Iuvone T (2002) The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J Biol Chem 277:50348-50354.
54. Fan GH, Wang LZ, Qiu HC, Ma L, and Pei G (1999) Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol 56:39-45.
55. Fan XL, Zhang JS, Zhang XQ, and Ma L (2003) Chronic morphine treatment and withdrawal induce up-regulation of c-Jun N-terminal kinase 3 gene expression in rat brain. Neuroscience 122:997-1002.
56. Fecho K and Lysle DT (2000) Heroin-induced alterations in leukocyte numbers and apoptosis in the rat spleen. Cell Immunol 202:113-123.
57. Fecho K, Maslonek KA, Coussons-Read ME, Dykstra LA, and Lysle DT (1994) Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J Immunol 152:5845-5852.
58. Fernandis AZ, Prasad A, Band H, Klosel R, and Ganju RK (2004) Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23:157-167.
59. Fimiani C, Arcuri E, Santoni A, Rialas CM, Bilfinger TV, Peter D, Salzet B, and Stefano GB (1999a) Mu3 opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release. Cancer Lett 146:45-51.
60. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, and Stefano GB (1999b) Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 11:189-193.
61. Franke TF, Kaplan DR, and Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437.
62. Freier DO and Fuchs BA (1993) Morphine-induced alterations in thymocyte sub-populations of B6C3F1 mice. J Pharmacol Exp Ther 265:81-88.
63. Fuchs BA and Pruett SB (1993) Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors. J Pharmacol Exp Ther 266:417-423.
64. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (Lond) 399:597-601.
65. Garcia I, Perez-Castillo A, Moreno J, and Alemany S (1992) Beta-endorphin inhibits interleukin-2 release and expression of interleukin-2 receptors in concanavalin A-stimulated splenic lymphocytes. Lymphokine Cytokine Res 11:339-345.
66. Gekker G, Hu S, Wentland MP, Bidlack JM, Lockensgard JR, and Peterson PK (2004) Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther 309:600-606.
67. Ghahremani MH, Forget C, and Albert PR (2000) Distinct roles for Galpha(i)2 and Gbetagamma in signaling to DNA synthesis and Galpha(i)3 in cellular transformation by dopamine D2S receptor activation in BALB/c 3T3 cells. Mol Cell Biol 20:1497-1506.
68. Gironi M, Martinelli V, Brambilla E, Furlan R, Panerai AE, Comi G, and Sacerdote P (2000) Beta-endorphin concentrations in peripheral blood mononuclear cells of patients with multiple sclerosis: effects of treatment with interferon beta. Arch Neurol 57:1178-1181.
69. Gomez Del Pulgar T, De Ceballos ML, Guzman M, and Velasco G (2002) Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 277:36527-36533.
70. Grey A, Chen Q, Callon K, Xu X, Reid IR, and Cornish J (2002) The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. Endocrinology 143:4755-4763.
71. Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Resau JH, Wang JM, Ali H, Richardson R, Snyderman R, and Oppenheim JJ (1998a) Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. J Exp Med 188:317-325.
72. Grimm MC, Ben-Baruch A, Taub DD, Howard OM, Wang JM, and Oppenheim JJ (1998b) Opiate inhibition of chemokine-induced chemotaxis. Ann N Y Acad Sci 840:9-20.
73. Grognet A, Hertz F, and DeFeudis FV (1983) Comparison of the analgesic actions of THIP and morphine. Gen Pharmacol 14:585-589.
74. Guan L, Eisenstein TK, Adler MW, and Rogers TJ (1997) Inhibition of T cell superantigen responses following treatment with the kappa-opioid agonist U50,488H. J Neuroimmunol 75:163-168.
75. Guo CJ, Li Y, Tian S, Wang X, Douglas SD, and Ho WZ (2002) Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor. J Investig Med 50:435-442.
76. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, and Hebbel RP (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491-4498.
77. Gurwell JA, Nath A, Sun Q, Zhang J, Martin KM, Chen Y, and Hauser KF (2001) Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro. Neuroscience 102:555-563.
78. Harimaya Y, Koizumi K, Andoh T, Nojima H, Kuraishi Y, and Saiki I (2002) Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett 187:121-127.
79. Hart S, Fischer OM, and Ullrich A (2004) Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res 64:1943-1950.
80. Hatzoglou A, Bakogeorgou E, and Castanas E (1996) The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol 296:199-207.
81. Hedin KE, Bell MP, Huntoon CJ, Karnitz LM, and McKean DJ (1999) Gi proteins use a novel beta gamma- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes. J Biol Chem 274:19992-20001.
82. Ho MK and Wong YH (2001) G(z) signaling: emerging divergence from G(i) signaling. Oncogene 20:1615-1625.
83. Hosoi J, Ozawa H, and Granstein RD (1999) beta-Endorphin binding and regulation of cytokine expression in Langerhans cells. Ann N Y Acad Sci 885:405-413.
84. Hsueh CM, Chen SF, Ghanta VK, and Hiramoto RN (1995) Expression of the conditioned NK cell activity is beta-endorphin dependent. Brain Res 678:76-82.
85. Hsueh CM, Chen SF, Huang HJ, Ghanta VK, and Hiramoto RN (1996) Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity. Brain Res 737:263-268.
86. Hu S, Chao CC, Hegg CC, Thayer S, and Peterson PK (2000) Morphine inhibits human microglial cell production of and migration towards, RANTES. J Psychopharmacol 14:238-243.
87. Hu S, Sheng WS, Lokensgard JR, and Peterson PK (2002) Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42:829-836.
88. Hurle MA (2001) Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J Neurochem 77:486-492.
89. Ientile R, Ginoprelli T, Cannavo G, Picerno I, and Piedimonte G (1997) Effect of beta-endorphin on cell growth and cell death in human peripheral blood lymphocytes. J Neuroimmunol 80:87-92.
90. Iglesias M, Segura MF, Cornelia JX, and Olmos G (2003) Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44:482-492.
91. Ishikawa M, Tanno K, Kamo A, Takayanagi Y, and Sasaki K (1993) Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol Pharm Bull 16:762-766.
92. Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D, Trzyna E, Trent J, Peiper S, Zembala M, Ratajczak J, et al. (2003) Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 63:7926-7935.
93. Jessop DS, Richards LJ, and Harbuz MS (2002) Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation. Ann N Y Acad Sci 966:456-463.
94. Jiang Y, Yang W, Zhou Y, and Ma L (2003) Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin and cocaine administrations. Neurosci Lett 352:216-220.
95. Johnson N and Pasternak GW (1983) The binding to rat brain homogenates of Mr2034, a universal opiate. Life Sci 33:985-991.
96. Kam AY, Chan AS, and Wong YH (2004) Phosphatidylinositol-3 kinase is distinctively required for micro-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase. J Neurochem 89:391-402.
97. Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, and Castanas E (1997) Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol 335:255-265.
98. Kampa M, Hatzoglou A, Notas G, Niniraki M, Kouroumalis E, and Castanas E (2001) Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells. Cell Death Differ 8:943-952.
99. Kawase M, Sakagami H, Furuya K, Kikuchi H, Nishikawa H, Motohashi N, Morimoto Y, Varga A, and Molnar J (2002) Cell death-inducing activity of opiates in human oral tumor cell lines. Anticancer Res 22:211-214.
100. Kim MS, Cheong YP, So HS, Lee KM, Kim TY, Oh J, Chung YT, Son Y, Kim BR, and Park R (2001) Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 61:779-786.
101. Kim YR, Lee SY, Shin BA, and Kim KM (1999) Panax ginseng blocks morphine-induced thymic apoptosis by lowering plasma corticosterone level. Gen Pharmacol 32:647-652.
102. Koch T, Kroslak T, Mayer P, Raulf E, and Hollt V (1997) Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin- dependent protein kinase II in agonist-mediated desensitization. J Neurochem 69:1767-1770.
103. Kong LY, McMillian MK, Hudson PM, Jin L, and Hong JS (1997) Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther 280:61-66.
104. Kowalski J (1997) Effect of enkephalins and endorphins on cytotoxic activity of natural killer cells and macrophages/monocytes in mice. Eur J Pharmacol 326: 251-255.
105. Kramer HK, Onoprishvili I, Andria ML, Hanna K, Sheinkman K, Haddad LB, and Simon EJ (2002) Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacol 2:5.
106. Kramer HK and Simon EJ (2000) mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. Neuropharmacology 39:1707-1719.
107. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, et al. (2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci USA 100:15184-15189.
108. Kugawa F, Arae K, Ueno A, and Aoki M (1998) Buprenorphine hydrochloride induces apoptosis in NG108-15 nerve cells. Eur J Pharmacol 347:105-112.
109. Kugawa F, Ueno A, and Aoki M (2000) Apoptosis of NG108-15 cells induced by buprenorphine hydrochloride occurs via the caspase-3 pathway. Biol Pharm Bull 23:930-935.
110. Law PY and Bergsbaken C (1995) Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. J Pharmacol Exp Ther 272:322-332.
111. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, and Loh HH (2000) Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275:32057-32065.
112. Law PY, McGinn TM, Campbell KM, Erickson LE, and Loh HH (1997) Agonist activation of delta-opioid receptor but not mu-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Mol Pharmacol 51:152-160.
113. Li JG, Luo LY, Krupnick JG, Benovic JL, and Liu-Chen LY (1999) U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 274: 12087-12094.
114. Li Y, Gonzalez MI, Meinkoth JL, Field J, Kazanietz MG, and Tennekoon GI (2003) Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells. J Biol Chem 278:9585-9591.
115. Li Y, Wang X, Tian S, Guo CJ, Douglas SD, and Ho WZ (2002) Methadone enhances human immunodeficiency virus infection of human immune cells. J Infect Dis 185:118-122.
116. Liu B, Qin L, Yang SN, Wilson BC, Liu Y, and Hong JS (2001) Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharmacol Exp Ther 298:1133-1141.
117. Liu JG, Liao XP, Gong ZH, and Qin BY (1999) Methadone-induced desensitization of the delta-opioid receptor is mediated by uncoupling of receptor from G protein. Eur J Pharmacol 374:301-308.
118. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup BA, and Landau NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
119. Lokensgard JR, Gekker G, and Peterson PK (2002) Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. Biochem Pharmacol 63:1037-1041.
120. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, and Wetzker R (1997) Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science (Wash DC) 275:394-397.
121. Lou L, Zhou T, Wang P, and Pei G (1999) Modulation of Ca2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of alpha and beta isoforms. Mol Pharmacol 55:557-563.
122. Lu ZW, Dai WJ, Wang GL, and Lin ZB (1996) Subchronic in vivo treatments of morphine inhibit T-cell proliferation by acting on macrophages. Brain Behav Immun 10:351-363.
123. Lysle DT and How T (2000) Heroin modulates the expression of inducible nitric oxide synthase. Immunopharmacology 46:181-192.
124. Ma W, Zheng WH, Powell K, Jhamandas K, and Quirion R (2001) Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 14:1091-1104.
125. Machelska H, Cabot PJ, Mousa SA, Zhang Q, and Stein C (1998) Pain control in inflammation governed by selectins. Nat Med 4:1425-1428.
126. Machelska H, Mousa SA, Brack A, Schopohl JK, Rittner HL, Schafer M, and Stein C (2002) Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 22:5588-5596.
127. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, and Mayo MW (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20:1626-1638.
128. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, and Stefano GB (1996) Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 156:4845-4850.
129. Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, and Nair MP (2002) Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol 169:3589-3599.
130. Maier U, Babich A, and Nurnberg B (1999) Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 274:29311-29317.
131. Mandler RN, Biddison WE, Mandler R, and Serrate SA (1986) beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol 136:934-939.
132. Maneckjee R, Biswas R, and Vonderhaar BK (1990) Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res 50:2234-2238.
133. Maneckjee R and Minna JD (1990) Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87:3294-3298.
134. Maneckjee R and Minna JD (1992) Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells. Proc Natl Acad Sci USA 89:1169-1173.
135. Maneckjee R and Minna JD (1994) Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 5:1033-1040.
136. Manes S, Mira E, Colomer R, Montero S, Real LM, Gomez-Mouton C, Jimenez-Baranda S, Garzon A, Lacalle RA, Harshman K, et al. (2003) CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med 198:1381-1389.
137. Mao J, Price DD, and Mayer DJ (1994) Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14:2301-2312.
138. Mao J, Price DD, and Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62:259-274.
139. Mao J, Sung B, Ji RR, and Lim G (2002) Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 22:7650-7661.
140. Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, and Parolaro D (2004) Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J Pharmacol Exp Ther 308:838-845.
141. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, and Rogers TJ (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62:111-123.
142. McCole DF, Keely SJ, Coffey RJ, and Barrett KE (2002) Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem 277:42603-42612.
143. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, and Lefkowitz RJ (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science (Wash DC) 290:1574-1577.
144. McDonald PH and Lefkowitz RJ (2001) Beta-Arrestins: new roles in regulating heptahelical receptors' functions. Cell Signal 13:683-689.
145. Melzig MF, Nylander I, Vlaskovska M, and Terenius L (1995) Beta-endorphin stimulates proliferation of small cell lung carcinoma cells in vitro via nonopioid binding sites. Exp Cell Res 219:471-476.
146. Meriney SD, Ford MJ, Oliva D, and Pilar G (1991) Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J Neurosci 11:3705-3717.
147. Meriney SD, Gray DB, and Pilar G (1985) Morphine-induced delay of normal cell death in the avian ciliary ganglion. Science (Wash DC) 228:1451-1453.
148. Mernenko OA, Blishchenko EY, Mirkina II, and Karelin AA (1996) Met-enkephalin induces cytolytic processes of apoptotic type in K562 human erythroid leukemia cells. FEBS Lett 383:230-232.
149. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H, and Yu L (1995) The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 15 (Pt 2):2396-2406.
150. Meunier JC, Kouakou Y, Puget A, and Moisand C (1983) Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Mol Pharmacol 24:23-29.
151. Miyagi T, Chuang LF, Doi RH, Carlos MP, Torres JV, and Chuang RY (2000) Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes. J Biol Chem 275:31305-31310.
152. Molina-Holgado E, Vela JM, Arevalo-Martin A, Almazan G, Molina-Holgado F, Borrell J, and Guaza C (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/ Akt signaling. J Neurosci 22:9742-9753.
153. Moon TD (1988) The effect of opiates upon prostatic carcinoma cell growth. Biochem Biophys Res Commun 153:722-727.
154. Mousa SA, Zhang Q, Sitte N, Ji R, and Stein C (2001) beta-Endorphin- containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71-78.
155. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, and Isner JM (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97:99-107.
156. Narita M, Imai S, Kasukawa A, Yajima Y, and Suzuki T (2004) Increased level of neuronal phosphoiositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception. Neuroscience 124:515-521.
157. Narita M, Mizoguchi H, Kampine JP, and Tseng LF (1996) Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br J Pharmacol 118:1829-1835.
158. Narita M, Mizoguchi H, Suzuki T, Dun NJ, Imai S, Yajima Y, Nagase H, and Tseng LF (2001) Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cgamma isoform. J Biol Chem 276:15409-15414.
159. Narita M, Ohnishi O, Nemoto M, Yajima Y, and Suzuki T (2002) Implications of phosphoinositide 3-kinase in the mu- and delta-opioid receptor-mediated supraspinal antinociception in the mouse. Neuroscience 113:647-652.
160. Narkar VA, Hussain T, Pedemonte C, and Lokhandwala MF (2001) Dopamine D(2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 12:1844-1852.
161. Navolotskaya EV, Malkova NV, Zargarova TA, Lepikhova TN, Krasnova SB, and Lipkin VM (2002a) Effect of synthetic beta-endorphin-like peptide immunorphin on human T lymphocytes. Biochemistry 67:357-363.
162. Navolotskaya EV, Zargarova TA, Malkova NV, Krasnova SB, Zav'yalov VP, and Lipkin VM (2002b) beta-Endorphin-like peptide SLTCLVKGFY is a selective agonist of nonopioid beta-endorphin receptor. Biochem Biophys Res Commun 292:799-804.
163. Neudeck BL and Loeb JM (2002) Endomorphin-1 alters interleukin-8 secretion in Caco-2 cells via a receptor mediated process. Immunol Lett 84:217-221.
164. Ni X, Lin BC, Song CY, and Wang CH (1999) Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes. Neuropeptides 33:137-143.
165. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, and Nestler EJ (1995) Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15: 1285-1297.
166. Pacifici R, di Carlo S, Bacosi A, Pichini S, and Zuccaro P (2000) Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int J Immunopharmacol 22:603-614.
167. Page GG, Ben-Eliyahu S, Yirmiya R, and Liebeskind JC (1993) Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54:21-28.
168. Pai R, Nakamura T, Moon WS, and Tarnawski AS (2003) Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J 17:1640-1647.
169. Pak Y, O'Dowd BF, Wang JB, and George SR (1999) Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase. J Biol Chem 274:27610-27616.
170. Panerai AE, Manfredi B, Granucci F, and Sacerdote P (1995) The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine/autocrine effects of the opioid. J Neuroimmunol 58:71-76.
171. Patel K, Bhaskaran M, Dani D, Reddy K, and Singhal PC (2003) Role of heme oxygenase-1 in morphine-modulated apoptosis and migration of macrophages. J Infect Dis 187:47-54.
172. Persson AI, Thorlin T, Bull C, and Eriksson PS (2003) Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors. Mol Cell Neurosci 23:360-372.
173. Peterson PK, Gekker G, Hu S, Lokensgard J, Portoghese PS, and Chao CC (1999) Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology 38:273-278.
174. Peterson PK, Gekker G, Lokensgard JR, Bidlack JM, Chang AC, Fang X, and Portoghese PS (2001) Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol 61:1145-1151.
175. Philippe D, Dubuquoy L, Groux H, Bran V, Chuoi-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, and Desreuraaux P (2003) Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Investig 111:1329-1338.
176. Pierce KL and Lefkowitz RJ (2001) Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2:727-733.
177. Polakiewicz KD, Schieferl SM, Dorner LF, Kansra V, and Comb MJ (1998a) A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization. J Biol Chem 273:12402-12406.
178. Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N, and Comb MJ (1998b) mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273:23534-23541.
179. Provinciali M, Di Stefane G, Stronati S, Raffaeli W, Pari G, and Fabris N (1996) Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients. Int J Immunopharmacol 18:577-586.
180. Przewlocki R, Hassan AH, Lason W, Epplen C, Herz A, and Stein C (1992) Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48:491-500.
181. Raghavendra V, Rutkowski MD, and DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22:9980-9989.
182. Refojo D, Kovalovsky D, Young JI, Rubinstein M, Holsboer F, Reul JM, Low MJ, and Arzt E (2002) Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice. J Neuroimmunol 131:126-134.
183. Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schafer M, and Stein C (2001) Opioid peptide-expressing leukocytes: identification, recruitment and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95:500-508.
184. Robinson SC, Scott KA, Wilson JL, Thompson RG, Proudfoot AE, and Balkwill FR (2003) A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 63:8360-8365.
185. Rogers TJ and Peterson PK (2003) Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24:116-121.
186. Rogers TJ, Steele AD, Howard OM, and Oppenheim JJ (2000) Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann N Y Acad Sci 917:19-28.
187. Roy S, Cain KJ, Chapin RB, Charboneau RG, and Barke RA (1998) Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun 245:392-396.
188. Roy S, Wang J, Gupta S, Charboneau R, Loh HH, and Barke RA (2004) Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol 147:78-81.
189. Rozenfeld-Granot G, Toren A, Amariglio N, Nagler A, Rosenthal E, Biniaminov M, Brok-Simoni F, and Rechavi G (2002) MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells. Exp Hematol 30:473-480.
190. Sacerdote P (2003) Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages. Ann N Y Acad Sci 992:129-140.
191. Sales KJ, Maudsley S, and Jabbour HN (2004) Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways Mol Endocrinol 18:1533-1545.
192. Sanchez C, de Ceballos ML, del Pulgar TG, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramon y Cajal S, and Guzman M (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61:5784-5789.
193. Sasamura T, Nakamura S, Iida Y, Fujii H, Murata J, Saiki I, Nojima H, and Kuraishi Y (2002) Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 441:185-191.
194. Schafer B, Gschwind A, and Ullrich A (2004) Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23:991-999.
195. Schafer M, Carter L, and Stein C (1994) Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91:4219-4223.
196. Schmidt H, Schulz S, Klutzny M, Koch T, Handel M, and Hollt V (2000) Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells. J Neurochem 74:414-422.
197. Schulz R, Wehmeyer A, and Schulz K (2002) Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J Pharmacol Exp Ther 300:376-384.
198. Schwindinger WF and Robishaw JD (2001) Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 20:1653-1660.
199. Sergeeva MG, Grishina ZV, and Varfolomeyev SD (1993) Morphine effect on proliferation of normal and tumor cells of immune origin. Immunol Lett 36:215-218.
200. Shahabi NA, Daaka Y, McAllen K, and Sharp BM (1999) Delta opioid receptors expressed by stably transfected jurkat cells signal through the map kinase pathway in a ras-independent manner. J Neuroimmunol 94:48-57.
201. Shahabi NA, Heagy W, and Sharp BM (1996) Beta-endorphin enhances Concanavalin-A-stimulated calcium mobilization by murine splenic T cells. Endocrinology 137:3386-3393.
202. Shahabi NA, McAllen K, Matta SG, and Sharp BM (2000) Expression of delta opioid receptors by splenocytes from SEB-treated mice and effects on phosphorylation of MAP kinase. Cell Immunol 205:84-93.
203. Shahabi NA and Sharp BM (1993) Activation of protein kinase C rapidly down-regulates naloxone-resistant receptors for beta-endorphin on U937 cells. J Pharmacol Exp Ther 264:276-281.
204. Shapira M, Gafni M, and Sarne Y (2003) Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation. Brain Res 960:190-200.
205. Sharp BM, Gekker G, Li MD, Chao CC, and Peterson PK (1998a) Delta-opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat). Biochem Pharmacol 56:289-292.
206. Sharp BM, McAllen K, Gekker G, Shahabi NA, and Peterson PK (2001) Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4+ T cells and DOR-dependent suppression of HIV-1 expression. J Immunol 167:1097-1102.
207. Sharp BM, McKean DJ, McAllen K, and Shahabi NA (1998b) Signaling through delta opioid receptors on murine splenic T cells and stably transfected Jurkat cells. Ann N Y Acad Sci 840:420-424.
208. Shen KF and Grain SM (1997) Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 757:176-190.
209. Sheng WS, Hu S, Lokensgard JR, and Peterson PK (2003) U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol 65:9-14.
210. Shenoy SK, McDonald PH, Kohout TA, and Lefkowitz RJ (2001) Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science (Wash DC) 294:1307-1313.
211. Shoda T, Fukuda K, Uga H, Mima H, and Morikawa H (2001) Activation of mu-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade. Anesthesiology 95:983-989.
212. Simon RH and Arbo TE (1986) Morphine increases metastatic tumor growth. Brain Res Bull 16:363-367.
213. Singh VK, Bajpai K, Narayan P, Yadav VS, Dhawan VC, Haq W, Mathur KB, and Agarwal SS (1999) Delta-opioid receptor antagonist inhibits immunomodulation by Met-enkephalin analogs. Neuroimmunomodulation 6:355-360.
214. Singhal P, Kapasi A, Reddy K, and Franki N (2001) Opiates promote T cell apoptosis through JNK and caspase pathway. Adv Exp Med Biol 493:127-135.
215. Singhal PC, Bhaskaran M, Patel J, Patel K, Kasinath BS, Duraisamy S, Franki N, Reddy K, and Kapasi AA (2002) Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 168:4025-4033.
216. Singhal PC, Kapasi AA, Franki N, and Reddy K (2000) Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology 100:57-62.
217. Singhal PC, Kapasi AA, Reddy K, Franki N, Gibbons N, and Ding G (1999) Morphine promotes apoptosis in Jurkat cells. J Leukoc Biol 66:650-658.
218. Singhal PC, Sharma P, Sanwal V, Prasad A, Kapasi A, Ranjan R, Franki N, Reddy K, and Gibbons N (1998) Morphine modulates proliferation of kidney fibroblasts. Kidney Int 53:350-357.
219. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, and Goligorsky MS (1995) Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 270:30290-30293.
220. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, and Herz A (1990) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 87:5935-5939.
221. Stiene-Martin A, Gurwell JA, and Hauser KF (1991) Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation. Brain Res Dev Brain Res 60:1-7.
222. Stiene-Martin A and Hauser KF (1993) Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and striatum. Neurosci Lett 157:1-3.
223. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B et al. (1995) Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science (Wash DC) 269:690-693.
224. Sueoka E, Sueoka N, Kai Y, Okabe S, Suganuma M, Kanematsu K, Yamamoto T, and Fujiki H (1998) Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun 252:566-570.
225. Sueoka N, Sueoka E, Okabe S, and Fujiki H (1996) Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression. Carcinogenesis 17:2337-2341.
226. Sundar KS, Kamaraju LS, Dingfelder J, McMahon J, Gollapudi S, Wilson WH, Kong LY, Hong JS, Weiss JM, and Lee JE (1995) beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. J Neuroimmunol 61:97-104.
227. Suzuki S, Chuang AJ, Chuang LF, Doi RH, and Chuang RY (2002a) Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis 185:1826-1829.
228. Suzuki S, Chuang LF, Yau P, Doi RH, and Chuang RY (2002b) Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp Cell Res 280:192-200.
229. Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, and Rogers TJ (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 99: 10276-10281.
230. Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM, et al. (2003) Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 74:1074-1082.
231. Takahashi T, Kamimura A, Hamazono-Matsuoka T, and Honda S (2003) Phosphatidic acid has a potential to promote hair growth in vitro and in vivo and activates mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in hair epithelial cells. J Investig Dermatol 121:448-456.
232. Takeba Y, Suzuki N, Kaneko A, Asai T, and Sakane T (2001) Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 28:2176-2183.
233. Takuwa Y, Takuwa N, and Sugimoto N (2002) The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J Biochem 131:767-771.
234. Tanimoto T, Lungu AO, and Berk BC (2004) Sphingosine 1-phosphate transactivates the platelet-derived growth actor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 94:1050-1058.
235. Tegeder I, Grosch S, Schmidtko A, Haussler A, Schmidt H, Niederberger E, Scholich K, and Geisslinger G (2003) G protein-independent G(1) cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 63:1846-1852.
236. Tian M, Broxmeyer HE, Fan Y, Lai Z, Zhang S, Aronica S, Cooper S, Bigsby RM, Steinmetz R, Engle SJ, et al. (1997) Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J Exp Med 185:1517-1522.
237. Tsai YC, Won SJ, and Lin MT (2000) Effects of morphine on immune response in rats with sciatic constriction injury. Pain 88:155-160.
238. Ueda H, Inoue M, and Matsumoto T (2001) Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia. J Neurosci 21:2967-2973.
239. van den Bergh P, Rozing J, and Nagelkerken L (1991) Two opposing modes of action of beta-endorphin on lymphocyte function. Immunology 72:537-543.
240. Vara Prasad MV, Shore SK, and Dhanasekaran N (1994) Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene 9:2425-2429.
241. Voyno-Yasenetskaya TA, Pace AM, and Bourne HR (1994) Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 9:2559-2565.
242. Wang D, Tolbert LM, Carlson KW, and Sadee W (2000) Nuclear Ca2+/calmodulin translocation activated by mu-opioid (OP3) receptor. J Neurochem 74:1418-1425.
243. Wetzel MA, Steele AD, Eisenstein TK, Adler MW, Henderson EE, and Rogers TJ (2000) Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. J Immunol 165:6519-6524.
244. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci USA 95:9914-9919.
245. Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, and Mitchell JB (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19:711-721.
246. Wolozin BL and Pasternak GW (1981) Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci USA 78:6181-6185.
247. Wong YH, Chan JS, Yung LY, and Bourne HR (1995) Mutant alpha subunit of Gz transforms Swiss 3T3 cells. Oncogene 10:1927-1933.
248. Wu WR, Zheng JW, Li N, Bai HQ, Zhang KR, and Li Y (1999) Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice. Eur J Pharmacol 366:61-69.
249. Xiang B, Yu GH, Guo J, Chen L, Hu W, Pel G, and Ma L (2001) Heterologous activation of protein kinase C stimulates phosphorylation of delta-opioid receptor at serine 344, resulting in beta-arrestin- and clathrin-mediated receptor internalization. J Biol Chem 276:4709-4716.
250. Xu N, Voyno-Yasenetskaya T, and Gutkind JS (1994) Potent transforming activity of the G13 alpha subunit defines a novel family of oncogenes. Biochem Biophys Res Commun 201:603-609.
251. Yeager MP and Colacchio TA (1991) Effect of morphine on growth of metastatic colon cancer in vivo. Arch Surg 126:454-456.
252. Yeager MP, Procopio MA, DeLeo JA, Arruda JL, Hildebrandt L, and Howell AL (2002) Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans. Anesth Analg 94:94-99.
253. Yin D, Mufson RA, Wang R, and Shi Y (1999) Fas-mediated cell death promoted by opioids. Nature (Lond) 397:218.
254. Yin DL, Ren XH, Zheng ZL, Pu L, Jiang LZ, Ma L, and Pei G (1997) Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins. Neurosci Res 29:121-127.
255. Zagon IS and McLaughlin PJ (1983) Naltrexone modulates tumor response in mice with neuroblastoma. Science (Wash DC) 221:671-673.
256. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.
257. Zhang L and Rogers TJ (2000) Kappa-opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression. J Immunol 164:5088-5093.
258. Zhang N, Hodge D, Rogers TJ, and Oppenheim JJ (2003a) Ca2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J Biol Chem 278:12729-12736.
259. Zhang WB, Zhang Z, Ni YX, Wu YL, and Pei G (2003b) A novel function of Goalpha: mediation of extracellular signal-regulated kinase activation by opioid receptors in neural cells. J Neurochem 86:1213-1222.
260. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, and Bicknell R (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Investig 99:2625-2634.
261. Zong J and Pollack GM (2000) Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharm Res (NY) 17:749-753.